1.Expression of anti-gp96 scFv fragment in Pichia pastoris and identification of its biological activity.
Mingming GUI ; Huiying WU ; Lu SUN ; Yaxing XU ; Bao ZHAO ; Xin LI ; Changfei LI ; Xidong WANG ; Songdong MENG
Chinese Journal of Biotechnology 2014;30(4):595-604
Secretory anti-gp96 scFv fragment was expressed in Pichia pastoris to obtain a small molecule antibody that specifically recognizes heat shock protein gp96. The gp96-scFv fragment gene was synthesized and cloned to Pichia pastoris expression plasmid pPICZa-A. Pichia pastoris X33 was electroporated with the linearized recombinant expression vector, and expression of gp96-scFv fragment was induced by methanol. The His-tagged recombinant protein was then purified by affinity chromatography and analyzed with SDS-PAGE and Western blotting assays. The biological activities of recombinant gp96-scFv fragment were determined by Western blotting, Immunofluorescence, ELISA and FACS assays. The gp96-scFv fragment was expressed successfully in Pichia pastoris. About 50 mg of recombinant protein could be purified from 1 liter of the Pichia pastoris culture supernatant. Its molecular weight was about 15 kDa. The gp96-scFv fragment could specifically bind to gp96 protein by Western blotting, immunofluorescence, ELISA and FACS analyses. Pichia pastoris-expressed gp96-scFv fragment specifically recognizes gp96 protein, which could be used for Western blotting, Immunofluorescence, ELISA and FACS analyses.
Blotting, Western
;
Chromatography, Affinity
;
Electrophoresis, Polyacrylamide Gel
;
Enzyme-Linked Immunosorbent Assay
;
Membrane Glycoproteins
;
immunology
;
Pichia
;
metabolism
;
Plasmids
;
Recombinant Proteins
;
biosynthesis
;
Single-Chain Antibodies
;
biosynthesis
2.A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.
Lu SUN ; Yu ZHANG ; Bao ZHAO ; Mengmeng DENG ; Jun LIU ; Xin LI ; Junwei HOU ; Mingming GUI ; Shuijun ZHANG ; Xiaodong LI ; George F GAO ; Songdong MENG
Protein & Cell 2014;5(4):317-327
Cytotoxic T cells (CTLs) play a key role in the control of Hepatitis B virus (HBV) infection and viral clearance. However, most of identified CTL epitopes are derived from HBV of genotypes A and D, and few have been defined in virus of genotypes B and C which are more prevalent in Asia. As HBV core protein (HBc) is the most conservative and immunogenic component, in this study we used an overlapping 9-mer peptide pool covering HBc to screen and identify specific CTL epitopes. An unconventional HLA-A2-restricted epitope HBc141-149 was discovered and structurally characterized by crystallization analysis. The immunogenicity and anti-HBV activity were further determined in HBV and HLA-A2 transgenic mice. Finally, we show that mutations in HBc141-149 epitope are associated with viral parameters and disease progression in HBV infected patients. Our data therefore provide insights into the structure characteristics of this unconventional epitope binding to MHC-I molecules, as well as epitope specific CTL activity that orchestrate T cell response and immune evasion in HBV infected patients.
Adult
;
Amino Acid Sequence
;
Animals
;
Binding Sites
;
Epitopes
;
chemistry
;
immunology
;
metabolism
;
Female
;
Genotype
;
HEK293 Cells
;
HLA-A2 Antigen
;
metabolism
;
Hepatitis B Core Antigens
;
chemistry
;
immunology
;
metabolism
;
Hepatitis B virus
;
genetics
;
metabolism
;
Humans
;
Hydrogen Bonding
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Mice, Transgenic
;
Middle Aged
;
Molecular Dynamics Simulation
;
Mutation
;
Protein Binding
;
Protein Structure, Tertiary
;
T-Lymphocytes, Cytotoxic
;
immunology
;
metabolism